Digital health companies selling to payers, providers, and employers contend with long sales cycles, large buying committees, and only a handful of accounts that truly matter. Spray-and-pray demand gen is the wrong approach. Account-based marketing aligns the entire go-to-market around the specific accounts that drive your revenue – and it succeeds only when marketing and sales work as one. We build and operate the ABM program that wins enterprise health deals.
The Challenge
Your buyer is a committee spanning clinicians, IT, procurement, and finance, and generic marketing connects with none of them
Enterprise health deals are decided by a buying group where a CMO, a CIO, a procurement lead, and a CFO all have a veto, and each cares about something completely different. Broad demand-gen content speaks to none of them well because it is written for no one specifically. Winning requires messaging tailored to each role inside a target account, coordinated across the committee. Most digital health marketing is built for volume and simply cannot operate at that resolution.
Sales cycles last 9 to 18 months, and your marketing has no way to remain relevant throughout them
Health system and payer deals take a year or more, involve pilots and security reviews, and stall in ways a normal SaaS funnel never does. Marketing that is optimized for fast MQLs goes quiet exactly when a long enterprise deal needs sustained, account-specific air cover. Without a program built for the long cycle, momentum dies between sales touches and deals slip. ABM exists precisely to keep the right accounts warm across a cycle that outlasts most marketing patience.
Marketing and sales are evaluated on different outcomes and quietly end up working against each other
When marketing chases lead volume and sales chases named accounts, the two teams optimize for goals that do not align, and enterprise health deals fall through the gap. Marketing generates leads sales does not want; sales pursues accounts marketing never supports. In a committee-driven, long-cycle sale this misalignment is fatal, because the account needs coordinated pressure from both. ABM only works when marketing and sales share one target list and one definition of success.
You are stretching limited dollars across a massive market rather than focusing them where deals actually close
The addressable market in digital health looks enormous, which tempts teams to market broadly, but revenue is concentrated in a relatively small set of accounts that fit your product and buying profile. Diluting budget across thousands of accounts that will never close wastes the spend that could have won the fifty that will. In enterprise health, concentration beats coverage. The hard part is choosing the right accounts and having the discipline to ignore the rest.
How We Help
We begin by building the target account list with sales, rather than for them. Drawing on your ICP, win history, and genuine buying-profile signals, we identify the specific payers, provider systems, or employers where your product fits and deals can realistically close, then secure sales commitment to that list. A shared, agreed-upon account list is the foundation – without one, ABM is simply expensive advertising.
Next, we map the buying committee within every account tier. We identify the roles with influence and veto authority – clinical, IT, security, procurement, finance – and develop role-specific messaging that addresses what each actually cares about. This is the level of precision enterprise health requires, and it turns account-based activity into committee-level traction instead of relying on one champion who cannot move the deal through.
Then we create the program that maintains attention throughout a long cycle. We develop account-specific content, coordinated touches, and air cover to keep target accounts engaged through pilots, security reviews, and procurement, aligning every play with each account's position in the cycle. The goal is to remain relevant for 9 to 18 months, not generate a single spike of interest and vanish.
For execution, we serve as the connective tissue between marketing and sales. We operate the account plays, provide sales with the signals and support required for each account, and keep both teams working from one list toward one definition of success. This is where most ABM falls apart, so we embed and execute instead of delivering a strategy and hoping the teams coordinate independently.
For measurement, we monitor account engagement, pipeline created and advanced within the target list, and closed deals – not lead volume. We assess whether the right accounts are progressing through the cycle and connect marketing activity to sales results on named accounts. MQL counts do not matter here; account progression and closed revenue define the scorecard.
What sets us apart is that we operate ABM as an embedded partner between your marketing and sales teams, concentrating on the small group of accounts that generates your revenue. Winning enterprise health deals takes someone who can create the account list, tailor the approach to the committee, and maintain alignment across a lengthy cycle, and that is where we work.
What we deliver
- Sales-aligned target account list built from ICP, win history, and real buying-profile signals
- Buying-committee maps with role-specific messaging for clinical, IT, security, procurement, and finance
- Account-specific content and coordinated touches designed to sustain engagement across a 9-to-18-month cycle
- Marketing-and-sales operating rhythm – shared list, shared success definition, and account plays run jointly
- Account-level measurement – engagement, target-list pipeline created and advanced, and closed revenue
In digital health enterprise sales, the greatest lever is not creating more demand – it is declining to pursue accounts that will never close. The teams that win the fifty accounts that matter are disciplined enough to disregard the thousands that don't.
Our Methodology
We deliver ABM through a 90-day sprint that establishes an ongoing program. The initial 30 days focus on targeting and alignment: we create the target account list with sales, map the buying committees, and secure both teams' commitment to one list and one definition of success. Days 30 through 60 focus on program build: we develop role-specific messaging and account content, then launch the first coordinated plays for tier-one accounts. Days 60 through 90 shift to operation and measurement: we execute the account plays, provide sales with the signals and support each account requires, and instrument account engagement and target-list pipeline.
Unlike a demand-gen agency, we act as the connective tissue between marketing and sales instead of throwing leads over the wall. In a committee-driven health sale with a long cycle, the program must maintain relevance for a year or longer, so plays follow the account's stage rather than a monthly MQL goal. We build from your actual win history and ICP, keep both teams focused on one account list, and evaluate the program through pipeline and closed revenue from named accounts.
Our Approach
The first 30 days focus on targeting and alignment. We develop the target account list alongside sales, map the buying committees within top-tier accounts, and secure marketing and sales commitment to one list and one definition of success. You receive an honest assessment of which accounts are genuinely winnable and where your current go-to-market is stretched too thin.
Days 30 through 60 focus on building the program. We create role-specific messaging and account-specific content, then launch the first coordinated plays against tier-one accounts. From your team, we require sales leadership engagement, CRM access, and product and clinical input to ensure the messaging is credible to a health buying committee.
Days 60 through 90 transition into operation and measurement. We execute the account plays, give sales the account signals and support they require, and instrument account engagement and target-list pipeline against your baseline. Since enterprise health cycles are lengthy, most engagements extend far beyond the initial sprint, with a typical first build lasting three to six months and ongoing operation continuing through the sales cycle.
Our cadence includes a weekly working session with both marketing and sales leads, along with async reporting on account movement and pipeline. We work within your existing revenue rhythm so ABM keeps the two teams aligned instead of operating as a standalone marketing project.
- Engagement and pipeline within the target account list
- Marketing and sales aligned on one list and one goal
- Committee-level traction, not single-champion deals
- Enterprise health deals advanced and closed
If your digital health company needs account-based marketing (abm) leadership, we should talk.
Expand your marketing team output with our experts
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Frequently asked questions
What does a digital health ABM engagement cost?
We price ABM using a fixed monthly fee based on the number of target accounts, the level of account-specific content, and the amount of marketing-and-sales operating support the program requires. A highly focused program covering a few dozen accounts is scoped differently from a tiered program spanning hundreds.
How soon will we see results from an ABM engagement?
Account engagement and pipeline progress among target accounts typically emerge within the first few months, while closed revenue follows the underlying sales cycle, which runs 9 to 18 months in enterprise health. Targeting, alignment, and the initial plays are established within 90 days.
How does the ABM team work with our existing staff?
We work as the connective tissue between your marketing and sales teams, so both need to participate. We require engagement from sales leadership, access to the CRM, and product and clinical input to create credible messaging.
What differentiates Winston Francois from a traditional ABM or demand-gen agency?
A demand-gen agency produces leads and passes them along. We embed between marketing and sales, develop a single shared target account list, customize messaging for the entire buying committee, and maintain alignment between both teams throughout a long health sales cycle.
How is ROI measured for an ABM engagement?
We measure account engagement, pipeline created and progressed within the target account list, and closed deals, all linked to named accounts instead of aggregate lead totals. MQL volume is intentionally omitted because it does not predict enterprise health outcomes. The scorecard tracks movement among the specific accounts that generate your revenue, measured against your pipeline baseline before the engagement.
What kind of digital health company is the right fit for this service?
This service is designed for digital health companies roughly in the 5M to 100M ARR range that sell to payers, provider systems, or employers, where deals are large, committee-driven, and concentrated among a knowable group of accounts. It performs best when sales leadership will commit to a shared account list. If you offer a low-ticket, high-volume consumer product, broad demand gen is a better fit. The process starts with a strategy call and a review of your ICP and win history.
